Published in Healthcare Mergers, Acquisitions and Ventures Week, February 11th, 2006
For the year, revenue grew 24% to $2.7 billion from $2.2 billion in the previous year.
Genzyme reported these and other preliminary, unaudited revenue figures in advance of a presentation by Chairman and CEO Henri A. Termeer at the JPMorgan 24th annual healthcare conference in San Francisco, California. The company will report full financial results for 2005 on February 15, 2006, when it will also provide additional financial guidance for 2006. Genzyme initially projects 2006 revenue of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week